Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

761 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 761 results

Testing effectiveness (Phase 2)Looking for participantsNCT06971614
What this trial is testing

T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Who this might be right for
Nonmuscle-invasive Bladder Cancer
ImmVira Pharma Co. Ltd 160
Large-scale testing (Phase 3)Ended earlyNCT02158936
What this trial is testing

Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Thrombocytopaenia
Novartis Pharmaceuticals 356
Post-approval studies (Phase 4)UnknownNCT00449098
What this trial is testing

Ologen (OculusGen)-Glaucoma MMC Control Trial in India

Who this might be right for
Glaucoma
Pro Top & Mediking Company Limited 40
Large-scale testing (Phase 3)Study completedNCT04401293
What this trial is testing

Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients

Who this might be right for
Sars-CoV2COVID
Northwell Health 257
Not applicableNot Yet RecruitingNCT07804485
What this trial is testing

Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H

Who this might be right for
High AltitudeHealthy AdultEchocardiography+3 more
Silvia Ulrich Somaini 14
Testing effectiveness (Phase 2)Ended earlyNCT02806258
What this trial is testing

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone

Who this might be right for
Radiation Therapy, Breast Cancer, Sequential Partial Breast IrradiationIntermediate and High-risk Luminal and Triple Negative Breast Cancer
University Hospital, Grenoble 362
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Early research (Phase 1)Study completedNCT00987376
What this trial is testing

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Not applicableStudy completedNCT02162290
What this trial is testing

Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program

Who this might be right for
Coronary Artery DiseaseMyocardial Infarction
Assaf-Harofeh Medical Center 84
Not applicableLooking for participantsNCT07452991
What this trial is testing

ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE

Who this might be right for
Pulmonary Embolism (PE)
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 300
Not applicableStudy completedNCT01927926
What this trial is testing

The Effects of Consuming Whey Protein Polydextrose Snacks on Appetite and Energy Intake

Who this might be right for
Obesity
University of Nottingham 10
Early research (Phase 1)WithdrawnNCT03057990
What this trial is testing

Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Montefiore Medical Center
Not applicableStudy completedNCT07012226
What this trial is testing

Comparison of Cardiometabolic Markers in Individuals With Hypertriglyceridemia With Low and High Weight Loss Responses to an Energy-restricted Diet

Who this might be right for
Obesity and OverweightHypertriglyceridaemia
Shahid Beheshti University of Medical Sciences 60
Not applicableUnknownNCT05749796
What this trial is testing

Investigation of the Relationship Between Development, Neurological Assessment and Object Permanence in High Risk Infants.

Who this might be right for
Infant Development
Tokat Gaziosmanpasa University 32
Testing effectiveness (Phase 2)UnknownNCT00657982
What this trial is testing

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sheba Medical Center 15
Not applicableActive Not RecruitingNCT07391137
What this trial is testing

CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC

Who this might be right for
Recurrence Free SurvivalBladder Cancer Recurrence
S. Andrea Hospital 250
Large-scale testing (Phase 3)Active Not RecruitingNCT04214067
What this trial is testing

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Who this might be right for
Endometrial Endometrioid AdenocarcinomaStage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableApproved For MarketingNCT04452136
What this trial is testing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic DiseasesProstate Cancer+2 more
Jeanne Link
Early research (Phase 1)Study completedNCT01303991
What this trial is testing

Hexvix Photodynamic Therapy in Patients With Bladder Cancer

Who this might be right for
Intermediate or High-risk Bladder Cancer
Photocure 17
Next Page